Five minutes with… James McCullough of Exosome Diagnostics
This article was originally published in Clinica
Executive Summary
James McCullough is co-founder and CEO of Exosome Diagnostics, a New York-based company that commercialises minimally-invasive molecular diagnostics using body fluids. Before taking control of the firm at its inception in 2008, he was the CEO of cardiovascular diagnostic firm AusAm Biotechnologies for more than five years